secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELLAS Life Sciences Group, Inc. (SLS)
CIK:        0001390478
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001104659-24-002295
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SELLAS Life Sciences prices $9.0M public offering of 12M shares and warrants at $0.75/unit
--------------------------------------------------------------------------------

- Gross proceeds of $9.0M from sale of 12M shares/common stock equivalents and 12M warrants at $0.75 per unit.
- Warrants exercise price $0.75 per share, immediately exercisable, expire in five years.
- A.G.P./Alliance Global Partners acting as sole placement agent; closing expected Jan 8, 2024.
- Exercise price reduced to $0.75 on ~7.5M warrants from prior issuances; term extended to Jan 8, 2029.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1390478/000110465924002295/0001104659-24-002295-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1390478/000110465924002295/tm242414d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-002295

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer